Callus Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.10 Cr
- Satisfied Charges ₹ 1.06 Cr
- Revenue Growth 9.78%
- Profit Growth -77.63%
- Ebitda -69.54%
- Net Worth 12.46%
- Total Assets 7.94%
About Callus Biotech
Callus Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 December 2008 and has a history of 16 years and one month. Its registered office is in Kolhapur, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.10 Cr. The company has closed loans amounting to ₹1.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Akshay Patil, Sudarshan Chavan, and Karan Shivajirao serve as directors at the Company.
Company Details
-
Location
Kolhapur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24211PN2008PTC133176
-
Company No.
133176
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Dec 2008
-
Date of AGM
24 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Callus Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akshay Patil
|
Director | 11-Dec-2008 | Current |
|
Sudarshan Chavan
|
Director | 11-Dec-2008 | Current |
|
Karan Shivajirao
|
Director | 15-Nov-2019 | Current |
Financial Performance of Callus Biotech.
Callus Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.78% increase. The company also saw a substantial fall in profitability, with a 77.63% decrease in profit. The company's net worth Soared by an impressive increase of 12.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Callus Biotech?
In 2023, Callus Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Association Of Plant Tissue Culture IndustriesAkshay Patil is a mutual person
-
Zexa Tech Private Limited
Karan Shivajirao is a mutual person
Charges (Loans)
₹20.95 M
₹10.65 M
Charges Breakdown by Lending Institutions
- Others : 2.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2024 | Others | ₹1.50 M | Open |
| 16 Mar 2023 | Others | ₹3.45 M | Open |
| 22 Dec 2020 | Others | ₹1.60 Cr | Open |
| 28 Feb 2019 | State Bank Of India | ₹5.00 M | Satisfied |
| 16 Apr 2014 | State Bank Of India | ₹1.50 M | Satisfied |
How Many Employees Work at Callus Biotech?
Unlock and access historical data on people associated with Callus Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Callus Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Callus Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
